Extracellular Vesicles: Molecular Research and Application
A special issue of Biomedicines (ISSN 2227-9059).
Deadline for manuscript submissions: closed (28 February 2022) | Viewed by 497
Special Issue Editor
2. Division of Periodontics, Section of Oral, Diagnostic and Rehabilitation Sciences, Columbia University College of Dental Medicine, New York, NY, USA
3. Cancer Biology and Immunology Laboratory, College of Dental Medicine, Columbia University Irving Medical Center, New York, NY, USA
Interests: CRISPR; exosomes; extracellular vesicles; innate immunity; tumor biology
Special Issue Information
Dear Colleagues,
Extracellular vesicles (EVs) are carriers of different biomacromolecules that participate in cellular signaling and disease pathogenesis. EVs contain a wide variety of macromolecules that represent samples of cytoplasmic or endosomal compartments and function in cell-to-cell paracrine and endocrine signaling; it has been demonstrated that pathological states such as oxidative stress, oncogenic transformation, apoptosis, and various cell injuries induce cells to release more EVs, simultaneously altering their composition to reflect the altered states of the cells of origin. Understanding EVs‘ biogenesis and biological roles could lead to novel insights into cellular crosstalk and complex biological pathways in cancer research. At the same time, this Special Issue particularly focuses on how EVs offer a solution for molecular cancer therapeutics, thereby providing an efficient and effective way to treat cancer.
Dr. Fatemeh Momen-Heravi
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- extracellular vesicles
- exosomes
- biomarker
- immunotherapy
- tumors
- cancer
